Med · 2024 · 39 citations · 15 references
MedicineOncologyPharmacotherapyBreast OncologyImmunotherapyMolecular OncologyAdjuvant TherapyCancer ImmunotherapyHer2-positive Breast CancerImmunotherapy For Breast CancerMalignant NeoplasmsMetastatic Breast CancerHer2 ExpressionHer2 InhibitorsHer2 Receptor SignalingHer2-positive Breast Cancer ImmunotherapyHer2-positive Breast Cancer TherapyLeptomeningeal EnhancementLeptomeningeal Spread
15
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Shanu Modi, William Jacot, Toshinari Yamashita et al. · New England Journal of Medicine · 2022 · 2.5K citations · Full text
Medicine, Oncology, Pharmacology +17
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Shanu Modi, Cristina Saura, Toshinari Yamashita et al. · New England Journal of Medicine · 2019 · 2K citations · Full text
Medicine, Oncology, Pharmacology +17
Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison et al. · Archives of Pathology & Laboratory Medicine · 2018 · 1.5K citations · Full text
Sara A. Hurvitz, Roberto Hegg, Wei‐Pang Chung et al. · The Lancet · 2022 · 642 citations · Full text
Medicine, Oncology, Pharmacology +16